Compare FPI & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FPI | NPCE |
|---|---|---|
| Founded | 2013 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 503.5M | 537.0M |
| IPO Year | 2013 | 2021 |
| Metric | FPI | NPCE |
|---|---|---|
| Price | $9.78 | $14.28 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | N/A | ★ $18.33 |
| AVG Volume (30 Days) | ★ 397.2K | 233.8K |
| Earning Date | 04-29-2026 | 05-12-2026 |
| Dividend Yield | ★ 3.14% | N/A |
| EPS Growth | N/A | ★ 29.03 |
| EPS | ★ 0.08 | N/A |
| Revenue | $52,178,000.00 | ★ $99,986,000.00 |
| Revenue This Year | N/A | $0.90 |
| Revenue Next Year | N/A | $24.46 |
| P/E Ratio | $124.00 | ★ N/A |
| Revenue Growth | N/A | ★ 25.13 |
| 52 Week Low | $9.21 | $8.19 |
| 52 Week High | $13.23 | $19.60 |
| Indicator | FPI | NPCE |
|---|---|---|
| Relative Strength Index (RSI) | 53.56 | 47.03 |
| Support Level | $9.39 | $13.84 |
| Resistance Level | $9.96 | $14.72 |
| Average True Range (ATR) | 0.20 | 0.82 |
| MACD | 0.03 | 0.12 |
| Stochastic Oscillator | 74.10 | 70.17 |
Farmland Partners Inc owns and seeks to acquire high-quality farmland throughout North America. The company is an internally managed real estate company which owns and contracts farmland and storage facilities located across the United States. Majority of the properties in its portfolio are used to grow primary crops, such as corn, soybeans, wheat, rice and cotton, and rest to produce specialty crops, such as almonds, pictachios, citrus, avacados, strawberies, and edible beans. The company generates its revenues through the rent it receives from its tenants.
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.